Shareholding disclosure

Basilea Pharmaceutica AG

Declared position

25.14%

Threshold

Crossed downwards

Timeline

Published

04.05.2023

Transaction

26.04.2023

Voting rights breakdown

Voting rights acquired8.73%

Voting rights sold25.14%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAN5200050

Beneficial owner

Basilea Pharmaceutica AG

Declared address

Basilea Pharmaceutica AG, 4051 Basel

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG, Allschwil04.05.2023TAN5200050

Disclosure summary

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the disposal side, published by SIX Exchange Regulation on 04.05.2023, at 25.14% of voting rights. Notice category: Single shareholder.

Disclosed position

25.14%

Voting rights sold

Voting rights acquired8.73%

Voting rights sold25.14%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Basilea Pharmaceutica AG disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 04.05.2023.

Publication date04.05.2023

Transaction date26.04.2023

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerBasilea Pharmaceutica AG

Declared addressBasilea Pharmaceutica AG, 4051 Basel

CategorySingle shareholder

Voting rights acquired8.73%

Voting rights sold25.14%

Below threshold0%

ExchangeXSWX

Notification IDTAN5200050

Commercial register

CHE-101.175.068

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 04.05.2023

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open